APA (7th ed.) Citation

Qiao, K., Guan, Y., & Xing, W. (2025). Interference with CHD1L inhibits the malignant progression and enhances cisplatin sensitivity of ovarian cancer cells by binding PLK1. Journal of ovarian research, 18(1), 38-15. https://doi.org/10.1186/s13048-024-01582-2

Chicago Style (17th ed.) Citation

Qiao, Kun, Yuanxiazi Guan, and Wenjing Xing. "Interference with CHD1L Inhibits the Malignant Progression and Enhances Cisplatin Sensitivity of Ovarian Cancer Cells by Binding PLK1." Journal of Ovarian Research 18, no. 1 (2025): 38-15. https://doi.org/10.1186/s13048-024-01582-2.

MLA (9th ed.) Citation

Qiao, Kun, et al. "Interference with CHD1L Inhibits the Malignant Progression and Enhances Cisplatin Sensitivity of Ovarian Cancer Cells by Binding PLK1." Journal of Ovarian Research, vol. 18, no. 1, 2025, pp. 38-15, https://doi.org/10.1186/s13048-024-01582-2.